Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Áåñïëîäíûé áðàê

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 29.09.2005, 23:11
Àâàòàð äëÿ Litta
Litta Litta âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 20.08.2005
Ãîðîä: Litva
Ñîîáùåíèé: 124
Litta ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Ýòî, äåéñòâèòåëüíî, ìàëîâåðîÿòíî òàê êàê ïåðåä îïåðàöèåé ïðîñèëà äîêòîðà âíèìàòåëüíî îñìîòðåòü ïðèäàòêè ñ ïðàâîé ñòîðîíû.
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 29.09.2005, 23:26
Àâàòàð äëÿ Litta
Litta Litta âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 20.08.2005
Ãîðîä: Litva
Ñîîáùåíèé: 124
Litta ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Äåëî â òîì, óâàæàåìàÿ Îëüãà, ÷òî óòî÷íèòü ðåçóëüòàòû ëàïàðîñêîïèè íå ïðåäñòàâëÿåòñÿ âîçìîæíûì (äëÿ ýòîãî ìíå ïðèä¸òñÿ ñíîâà ëå÷ü íà îïåðàöèîííûé ñòîë). Ïåðåä îïåðàöèåé äîêòîð áûë ïðåäóïðåæä¸í î âîçìîæíîì îòñóòñòâèè ïðèäàòêîâ ñ ïðàâîé ñòîðîíû è, ñîîòâåòñòâåííî, ÿ ïîïðîñèëà ñèòóàöèþ ïðîÿñíèòü. Íàäåþñü, ÷òî âî âðåìÿ îïåðàöèè òàì âñ¸ òùàòåëüíî ïîèñêàëè. Âûâîä îäèí - ïðèäàòêîâ ñ ïðàâîé ñòîðîíû íåò è íå áûëî íèêîãäà, ìàòêà îäíîðîãàÿ.
ÓÇÈ, êîíå÷íî, ÿ ñäåëàþ ñíîâà, íî íà ðóêàõ ó ìåíÿ åñòü ñíèìêè ÄÂÓÕ ÿè÷íèêîâ, êîòîðûå ñîâåðøåííî ðàçíûå ïî ðàçìåðàì è ôîðìå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 30.09.2005, 20:32
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâ. Ìèõàèë Âëàäèìèðîâè÷!



Ñòîëü ýìîöèîíàëüíîå èçëîæåíèå ñâîèõ ïîçèöèé ñâÿçàíî, åñòåñòâåííî, íå ñ îòíîøåíèåì ê Âàì ëè÷íî, à ñ îòíîøåíèåì ê îáñóæäàåìîé ïðîáëåìå. Âîçìîæíî ÿ è ïîãîðÿ÷èëñÿ, ïîýòîìó ïðèíîøó ñâîè èçâèíåíèÿ.



Åñòåñòâåííî, íå çàíèìàÿñü îïåðàòèâíîé õèðóðãèåé ÿ âîâñå íå ïëàíèðóþ îáñóæäàòü ñ Âàìè ïðåèìóùåñòâà òåõ èëè èíûõ ìåòîäîâ ðåêîíñòðóêòèâíîé õèðóðãè ïðè ðàçëè÷íûõ êëèíè÷åñêèõ ñèòóàöèÿõ. Êðîìå òîãî â ìîè ïëàíû íå âõîäèò è îáñóæäåíèå ðàçëè÷íûõ ìåòîäîâ ïðåðûâàíèÿ ýêòîïè÷åñêîé áåðåìåííîñòè.

À âîò ïåðñïåêòèâû ðåïðîäóêòèâíîãî çäîðîâüÿ, öåëåñîîáðàçíîñòü ïðîâåäåíèÿ òîãî èëè èíîãî ìåòîäà ëå÷åíèÿ ÁÅÑÏËÎÄÈß (âêëþ÷àÿ õèðóðãè÷åñêèå) – ýòà òåìà ìíå âåñüìà èíòåðåñíà.

Òåì íå ìåíåå, ÿ íå ïîëåíèëñÿ è äîñòàòî÷íî ñåðüåçíî ïðîøòóäèðîâàë èìåþùóþñÿ èíôîðìàöèþ, êàñàþùóþñÿ ðåêîíñòðóêòèâíîé õèðóðãèè ìàòî÷íûõ òðóá, õèðóðãè÷åñêîé òàêòèêè ïðè ýêòîïè÷åñêîé áåðåìåííîñòè, âàðèàíòàõ ïîñò-îïåðàöèîííîãî ëå÷åíèÿ è ò.ä.



Èòàê.



De mortius aut bene aut nihil. (Î ìåðòâûõ ëèáî õîðîøî, ëèáî íè÷åãî)


ß íàøåë íå ìåíåå ñîòíè èññëåäîâàíèé íà÷èíàÿ ñ 1990 ãîäà ïîñâÿùåííûõ íå òîëüêî îïåðàòèâíîé òàêòèêè íî ðåêîíñòðóêòèâíîé õèðóðãèè ìàòî÷íûõ òðóá â öåëîì. Ïðè èõ èçó÷åíèè ìåíÿ âñå âðåìÿ íå ïîêèäàëî îùóùåíèå, ÷òî ÿ èäó ïî áîëüøîìó èíòåðíàöèîíàëüíîìó êëàäáèùó, ãäå òóò è òàì ñëûøíû çàçäðàâíûå ðå÷è î âíåçàïíî óøåäøèõ â ìèð èíîé âåëèêèõ õèðóðãàõ. (Áîëüøèíñòâî ñòàòåé î÷åíü íàïîìèíàþò ìåìóàðû àâòîðîâ ñ îïèñàíèåì èõ ïîáåä).

Íó à åñëè ñåðüåçíî, òî ïîäàâëÿþùåå ÷èñëî ðàáîò ïî îïåðàòèâíîé òàêòèêå è ðåêîíñòðóêòèâíîé õèðóðãèè íå ðàíäîìèçèðîâàíû, ïðàêòè÷åñêè âñå (íàâåðíîå âñå, ïî êðàéíåé ìåðå ÿ íå ñìîã îáíàðóæèòü äðóãèõ) íîñÿò îïèñàòåëüíûé õàðàêòåð, à åñëè è ïðîâîäÿò àíàëèç, òî êàê ïðàâèëî ðåòðîñïåêòèâíûé.

ß ïðåêðàñíî ïîíèìàþ, ÷òî âûïîëíèòü ñåðüåçíîå èññëåäîâàíèå (ñ âûâåðåííûì äèçàéíîì) ýòî çíà÷èòåëüíûå çàòðàòû íå òîëüêî óìñòâåííûå, íî è ìàòåðèàëüíûå. Îäíàêî ïðè àíàëèçå ðåòðîñïåêòèâíûõ èññëåäîâàíèé óãàäûâàåòñÿ òîò ñóáúåêòèâèçì ,â ñèëó êîòîðîãî èõ äîêàçàòåëüíîñòü ñåðüåçíî ñòðàäàåò.

Òåì íå ìåíåå â îáçîðíûõ ìàòåðèàëàõ â ðàçíûõ èñòî÷íèêàõ ÷àùå âñåãî âñòðå÷àåòñÿ öèôðà 60%, êàê íàñòóïëåíèå áåðåìåííîñòè ïîñëå ïðîâåäåíèÿ ðåêîíñòðóêòèâíûõ îïåðàöèé íà ìàòî÷íûõ òðóáàõ.

Fertility after ectopic pregnancy and indications of ART J Gynecol Obstet Biol Reprod (Paris). 2003 Nov;32(7 Suppl):S83-92. Bouyer J, Fernandez H, Coste J, Pouly JL, Job-Spira N.

There is no simple answer to the problem of fertility after one ectopic pregnancy. Results reported in the literature have been satisfactory with rate of subsequent pregnancy about 60% and the risk of new ectopic pregnancy (EP) around 28%. We have deliberately excluded studies before 1990 except when the methodology was particularly good or the treatment particularly interesting. Strict and exhaustive criteria were lacking in most of these studies due to widely varying aims, the prospective or retrospective nature of the data, the number of patients included, and varying therapeutic decision-making schemes. Many patients were lost to and no mention is given concerning the proportion of patients who desired a subsequent pregnancy. Infertility factors were not considered in most cases. We were looking for fertility results according to treatment used. Among the 50 studies we retained, pregnancy rates after ectopic pregnancy were satisfactory whatever treatment was used, with laparoscopy being the gold standard. Medical treatment was at least as effective as surgical treatment. Associated infertility factors appeared to be the most important for fertility outcome. It is unfortunate that so few study have analyzed outcome in these patients without considering risks factors of EP, infertility factors and the proportion of women who attempted to conceive again.



Ìíîãî ýòî èëè ìàëî? Äóìàþ, ÷òî ìíîãî, ….

åñëè ðàññìàòðèâàòü òîò ôàêò, ÷òî ïî÷òè òðåòü èç íèõ (28%)- ýòî ïîâòîðíûå ýêòîïè÷åñêèå áåðåìåííîñòè.



×àñòîòà æå ýêòîïè÷åñêîé áåðåìåííîñòè ïðè ïðîâåäåíèè ïðîöåäóðû ýêñòðàêîðïîðàëüíîãî îïëîäîòâîðåíèÿ íà ïîðÿäîê íèæå è íå ïðåâûøàåò 4%.



BMC Pregnancy Childbirth. 2003 Nov 7;3(1):7. Milki AA, Jun SH.Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis.
BACKGROUND: Blastocyst transfer may theoretically decrease the incidence of ectopic pregnancy following IVF-ET in view of the decreased uterine contractility reported on day 5. The purpose of our study is to specifically compare the tubal pregnancy rates between day 3 and day 5 transfers. METHODS: A retrospective analysis of all clinical pregnancies conceived in our IVF program since 1998 was performed. The ectopic pregnancy rates were compared for day 3 and day 5 transfers. RESULTS: There were 623 clinical pregnancies resulting from day 3 transfers of which 22 were ectopic (3.5%). In day 5 transfers, there were 13 ectopic pregnancies out of 333 clinical pregnancies (3.9%). The difference between these rates is not statistically significant (P = 0.8).




Áîëüøèíñòâî ðàáîò âûïîëíåííûõ â 90-õ ãîäàõ äåéñòâèòåëüíî îäíîçíà÷íî ðàññìàòðèâàþò ïðîáëåìó òàêòèêè ëå÷åíèÿ ïðè òðóáíî-ïåðèòîíåàëüíîì áåñïëîäèè â ïîëüçó ðåêîíñòðóêòèâíîé õèðóðãèè. Îäíàêî ñëåäóåò ïîìíèòü, ÷òî â ýòî âðåìÿ (íà÷àëî 90-õ ) ýôôåêòèâíîñòü ïðèìåíåíèÿ ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè íå ïðåâûøàëî 10-15%, à äî 1978 ãîäà (ãîä ðîæäåíèÿ Ëóèçû Áðàóí, ïåðâîãî “ðåáåíêà èç ïðîáèðêè”) íèêàêèå àëüòåðíàòèâíûå ìåòîäû ëå÷åíèÿ òðóáíîãî áåñïëîäèÿ âîîáùå íå ðàññìàòðèâàëèñü.

Íå ìóäðåíî, ÷òî áîëüøèíñòâî ðàáîò ýòîãî âðåìåíè èññëåäóþò ðàçëè÷íûå âàðèàíòû óñîâåðøåíñòâîâàíèÿ îïåðàòèâíîãî âìåøàòåëüñòâà.

Îäíàêî óæå â ñåðåäèíå 90-õ ïîÿâëÿþòñÿ èññëåäîâàíèÿ, êîòîðûå ðàññìàòðèâàþò è ñðàâíèâàþò ýôôåêòèâíîñòü àëüòåðíàòèâíûõ ìåòîäîâ ëå÷åíèÿ.

ñì. äàëåå

Êîììåíòàðèè ê ñîîáùåíèþ:
dr_medvedev îäîáðèë(à): Ñïàñèáî çà ïîäðîáíûå îòâåòû. Îíè áóäóò ïîëåçíû ìíîãèì.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 30.09.2005, 20:39
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Fertil Steril. 1995 Dec;64(6):1051-61. In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Benadiva CA, Kligman I, Davis O, Rosenwaks Z.
Department of Obstetrics and Gynecology, New York Hospital-Cornell Medical
Center, New York 10021, USA.
OBJECTIVE: To compare the results of pelvic reconstructive surgery withcumulative success rates of IVF for couples with tubal factor infertility.

DATARESOURCES: Outcomes of pelvic surgery were obtained from a review of articlesfrom the literature identified by directed Medline searches. Cumulativepregnancy rates of 771 couples with tubal factor infertility treated at theCornell IVF program between December 1989 and December 1992 were calculated bylife-table analysis.

RESULTS: Overall delivery rate per transfer for patientswith tubal factor was 28.9% (303 deliveries per 1,048 transfers) and did notappear to be affected significantly by the presence of a secondary diagnosis. Asignificant decline in pregnancy rates was observed with advancing age: age < 30years, 48.4%; 30 to 34 years, 44%; 35 to 38 years, 28%; 39 to 40 years, 20%; 41to 42 years, 9%; and > 42 years, 4.3%. Cumulative pregnancy rates for cycles 1to 4 were 32%, 59%, 70%, and 77%, respectively, in patients with only tubalfactor, and 28%, 55%, 62%, and 75% in patients with tubal combined with otherassociated infertility factors.

CONCLUSIONS: Our experience suggest that > 70%of women with tubal factor infertility will have a live birth within four cyclesof treatment with IVF. These results compare favorably with the best outcomesafter tubal reconstructive surgery. In older women, because of the rapid declineof fertility potential with advancing age, efforts should be directed toward thetreatment method that provides the highest likelihood of success within theshortest time interval.



Ò.å. ïðè ñàìûõ îïòèìèñòè÷íûõ ðåçóëüòàòàõ ðåêîíñòðóêòèâíîé õèðóðãèè ïîëó÷àþòñÿ ñðàâíèìûå ðåçóëüòàòû (è ýòî â 1995, êîãäà òîëüêî íà÷èíàëàñü ýðà ïðèìåíåíèÿ àãîíèñòîâ â ïðîãðàììàõ ÂÐÒ, ÷òî â ïîñëåäñòâèè ñåðüåçíî èçìåíèëî ýôôåêòèâíîñòü ïðèìåíåíèÿ ýòèõ ìåòîäîâ), íî ìû íå çàáûâàåì îá îñëîæíåíèÿõ, è â ïåðâóþ î÷åðåäü î ïîâòîðíûõ ýêòîïè÷åñêèõ áåðåìåííîñòÿõ. Êðîìå òîãî ðàññìàòðèâàþòñÿ è äîïîëíèòåëüíûå ôàêòîðû, òàêèå êàê âîçðàñò è âðåìÿ äîñòèæåíèÿ æåëàåìîãî ðåçóëüòàò (áåðåìåííîñòè.)

Int J Fertil Menopausal Stud. 1995 Nov-Dec;40(6):297-302. Primary therapy for tubal disease: surgery versus IVF. Gocial B.

Philadelphia Fertility Institute, PA 19107, USA.

Infertility involves fallopian tube occlusion or other malfunction in over 25% of cases. Reconstructive surgery offers the possibility of natural conception, but the success rate overall is less than 30% and if the hydrosalpinx is severe or other factors are involved, much lower than that. IVF-ET currently offers a much higher success rate. Although the cost of IVF per cycle is over three-fourths the total cost of tubal surgery, the eventual success rate of IVF is so much better than that of surgery that the costs per baby delivered are some 10% lower. In addition, more infertile couples are rewarded in their quest to have a child.


Ò.å óæå â ñåðåäèíå 90-õ ñðàâíèâàåòñÿ öåëåñîîáðàçíîñòü ïðèìåíåíèÿ àëüòåðíàòèâíûõ ìåòîäîâ.



 ñâîåé ïðàêòèêå ÿ åæåäíåâíî ñòàëêèâàþñü ñ ïàöèåíòàìè êîòîðûå ïðîâîäèëè íåîäíîêðàòíûå ðåêîíñòðóêòèâíûå âìåøàòåëüñòâà íà ìàòî÷íûõ òðóáàõ. Âñåãäà ïîðàæàåò íè÷åì íå îáúÿñíèìîå óïîðñòâî (ÿ íå ðàññìàòðèâàþ ìàòåðèàëüíóþ çàèíòåðåñîâàííîñòü, õîòåëîñü áû äóìàòü ÷òî ýòîò ôàêòîð íå îêàçûâàåò âëèÿíèÿ íà ïðèíÿòèå ðåøåíèÿ) õèðóðãîâ, êîòîðûå ñ ðàçíèöåé â ãîä âûïîëíÿþò îäíî çà äðóãèì âìåøàòåëüñòâà, ïðè÷åì åñëè ñîáðàòü âñå ïðîòîêîëû âìåñòå (à ìíå ïðèõîäèëîñü âèäåòü äî 5 ïîñëåäîâàòåëüíûõ îïåðàöèé â àíàìíåçå), òî ïåðâîå, ÷òî áðîñàåòñÿ â ãëàçà – ýòî ïî÷òè èäåíòè÷íîå îïèñàíèå ñîñòîÿíèÿ âíóòðåííèõ îðãàíîâ íà ìîìåíò íà÷àëà îïåðàöèè è ñòàíäàðòíûå îïåðàòèâíûå äåéñòâèÿ. Îäíàêî ñïóñòÿ ãîä ïîñëå ïðîâåäåíèÿ âìåøàòåëüñòâà, òîò ñïàå÷íûé ïðîöåññ (à ïîñëå âìåøàòåëüñòâà ïî ïðåäøåñòâóþùåìó ïðîòîêîëó åãî óæå íåò), íåïðîõîäèìàÿ ìàòî÷íàÿ òðóáà (ñòàâøàÿ ïðîõîäèìîé ïîñëå âìåøàòåëüñòâà) ïðè ïîâòîðíîì âìåøàòåëüñòâå îïèñàíû êàê ïî øàáëîíó ãîäè÷íîé äàâíîñòè è …. ïðîâîäèòñÿ àíàëîãè÷íîå âìåøàòåëüñòâî. Ìíå ïðèõîäèëîñü âèäåòü ÏßÒÜ ïðîòîêîëîâ ó ÎÄÍÎÉ æåíùèíû.

Ê ñîæàëåíèþ íàéòè êàêèõ-ëèáî ñåðüåçíûõ ïóáëèêàöèé, îòíîñèòåëüíî öåëåñîîáðàçíîñòè ïðîâåäåíèÿ ïîâòîðíûõ âìåøàòåëüñòâ ïðè òðóáíî ïåðèòîíåàëüíîì áåñïëîäèè ìíå íå óäàëîñü (â îñíîâíîì îïèñàíèå êëèíè÷åñêèõ ñëó÷àåâ.).

Íåäîóìåíèå âûçûâàåò òàêòèêà ðåêîíñòðóêòèâíîé õèðóðãèè ó æåíùèí ñ âûðàæåííûì ñïàå÷íûì ïðîöåññîì â ìàëîì òàçó. Íåîäíîêðàòíî âñòðå÷àë ïàöèåíòîâ ïðèáëèçèòåëüíî ñ òàêèìè äàííûìè:
Ïåðèòîíèò. Ñïàå÷íûé ïðîöåññ 3-4 ñò. Äâóñò. ñàêòîñàëüïèíêñ => Ëàïàðîñêîïèÿ/ ëàïàðîòîìèÿ, “Ãåðîè÷åñêèå óñèëèÿ” õèðóðãà ïî îñâîáîæäåíèþ ìàòî÷íûõ òðóá, îïîðîæíåíèþ ñàêòîñàëüïèíêñîâ è èññå÷åíèþ ñïàåê=> Æåíùèíà æäåò ãîä, à òî è äâà, æäåò íàñòóïëåíèÿ áåðåìåííîñòè (ò.ê. îíà ñâÿòî âåðèò, ÷òî âñå ñïàéêè óäàëåíû, à òðóáû ñòàëè ñâîáîäíî ïðîõîäèìû)  ýòî âðåìÿ äëÿ çàêðåïëåíèÿ ðåçóëüòàòîâ âìåøàòåëüñòâà ïðèíèìàåò ÁÀÄû, õîäèò íà ãèíåêîëîãè÷åñêèé ìàññàæ (“óëó÷øàþùèé êðîâîñíàáæåíèå ìàòêè è ìàòî÷íûõ òðóá è ðàçäåëÿþùèé âíîâü îáðàçîâàííûå ñïàéêè”), èçìåðÿåò áàçàëüíóþ òåìïåðàòóðó (òàêîå âïå÷àòëåíèå ÷òî ýòà ïðèâû÷êà ïåðåäàåòñÿ ñ ìîëîêîì ìàòåðè) =>Ïîâòîðíîå îïåðàòèâíîå âìåøàòåëüñòâî=> Ñïàå÷íûé ïðîöåññ 3-4 ñò. Äâóñò. ñàêòîñàëüïèíêñ => ðåêîìåíäàöèè î ãîäè÷íîì îæèäàíèè. ìàññàæ ……=>

Çàòåì ïàöèåíòêà ïðèõîäèò ê íàì è, ïåðâîå ÷òî ìû åé ðåêîìåíäóåì – ýòî óäàëåíèå ñàêòîñàëüïèíêñîâ ïåðåä ïëàíèðóåìîé ïðîöåäóðîé ýêî ò.ê. èõ íàëè÷èå ïî÷òè âäâîå ñíèæàåò âåðîÿòíîñòü íàñòóïëåíèÿ áåðåìåííîñòè â ïðîãðàììàõ ÂÐÒ (âñïîìîãàòåëüíûå ðåïðîäóêòèâíûå òåõíîëîãèè)



ñì. äàëåå
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 30.09.2005, 20:55
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ReprodBiomedOnline. 2002;4 Suppl 3:37-9. How to treat hydrosalpinges: IVF as the treatment of choice.StrandellA.

Twotreatment options are available for patients suffering from tubalinfertility due to hydrosalpinges. Surgical distal tubal repair is appropriateonly for patients with preserved tubal mucosa, otherwise the subsequentintrauterine pregnancy rate is unacceptably low and the ectopic pregnancy ratetoo high. The alternative treatment, IVF, has also demonstrated low success ratein patients with untreated hydrosalpinges, possibly due to leakage of fluid intothe uterus. Salpingectomy has been suggested as a method to overcome thenegative influence of the hydrosalpingeal fluid on implantation and embryodevelopment. A randomized controlled trial in Scandinavia has demonstrated abenefit of salpingectomy in patients with hydrosalpinges that were large enoughto be visible on ultrasound. If only the first cycle was considered, patientshaving undergone salpingectomy expressed significantly higher clinical pregnancy(46% versus 22%) and birth (40% versus 17%) rates. It is concluded that patientswith large hydrosalpinges and without prospect of spontaneous conception shouldbe recommended salpingectomy, which truly increases their chances of asuccessful IVF treatment.

Êñòàòè áîëåå ðàäèêàëüíàÿ òàêòèêà õèðóðãè÷åñêîãî ëå÷åíèÿ ðàññìàòðèâàåòñÿ è áåç ñàêòîñàëüïèíêñîâ, íî ïðè óñëîâèè, ÷òî õèðóðã ïðåäïîëàãàåò, ÷òî ñóùåñòâóþò è äðóãèå (êðîìå õèðóðãè÷åñêèõ) ìåòîäû ËÅ×ÅÍÈß ÁÅÑÏËÎÄÈß:
Ceska Gynekol. 2001 Jul;66(4):259-64.Effect of salpingectomy on the results of IVF in women with tubalsterility-prospective study. Mardesic T, Muller P, Huttelova R, Zvarova J, Hulvert J, Voboril J, Becvarova V, Mikova M, Landova K, Jirkovsky M.
OBJECTIVE: To compare the IVF results after salpingectomy of hydrosalpinges


visible on ultrasound with IVF results in women with tubal infertility but without hydrosalpinx. DESIGN: Prospective study. SETTING: Sanatorium Pronatal, Na Dlouhe mezi 4/12, 147 00, Praha 4. METHODS: 101 women with tubal factor infertility were evaluated. In a prospective study we compared the results of first IVF cycle after salpingectomy of hydrosalpinges visible on ultrasound performed in 51 women (study group) with IVF results of 50 women with tubal infertility (confirmed by HSG and laparoscopy) but without hydrosalpinges and without salpingectomy. RESULTS: The maternal age in both groups (32.4 +/- 3.9 in salpingectomy group and 33.0 +/- 4.1 in control group), maximum estradiol levels (1392.6 +/- 675.8 pg/ml in salpingectomy group vers. 1624.7 +/- 909.7 pg/ml in control group), number of oocytes (11.3 +/- 5.8 after salpingectomy vers. 11.0 +/- 6.1 in controls), number of embryos generated (7.1 +/- 4.6 vers. 7.9 +/- 4.7) and number of embryos transferred were not statistically different. In their first IVF cycle after salpingectomy has been performed 30 women out of 51 became clinically pregnant (58.8%), while in control group a clinical pregnancy could be verified in 16 women (32.0%). Implantation rate in women aftersalpingectomy was 28.2% vers. 12.3% in control group. Both implantation rate and pregnancy rate were statistically different at 5% level of significance.
CONCLUSION: After salpingectomy of hydrosalpinges visible on ultrasound the
implantation rate and clinical pregnancy rate are significantly better whencompared to IVF patients with tubal infertility without the presence ofhydrosalpinges and without salpingectomy. Salpingectomy should be offered to allpatients with hydrosalpinges visible on ultrasound. Moreover, this radicalapproach should be considered even in women with highly damaged tubes butwithout the presence of hydrosalpinges.

Íàèáîëüøåå íåäîóìåíèå âûçûâàåò âûïîëíåíèå îðãàíñîõðàíÿþùèõ îïåðàöèé íà ìàòî÷íûõ òðóáàõ ïðè òðóáíîé áåðåìåííîñòè (îáû÷íî ïðè ðàçðûâå òðóáû) ñ ñîõðàíåíèåì êóëüòè òðóáû. Íåïîíÿòíî, ÷åì ðóêîâîäñòâóåòñÿ õèðóðã. Âäâîéíå îáèäíî, êîãäà ïîñëå âûïîëíåíèÿ ýêñòðàêîðïîðàëüíîãî îïëîäîòâîðåíèÿ áåðåìåííîñòü íàñòóïàåò èìåííî â îñòàâëåííîé êóëüòå ìàòî÷íîé òðóáû. Ïåðåä òåì êàê íà÷àòü ëå÷åíèå ìåòîäîì ýêî ÿ èíôîðìèðóþ ïàöèåíòà îá ýôôåêòèâíîñòè ëå÷åíèÿ, âîçìîæíûõ îñëîæíåíèÿõ, àëüòåðíàòèâíûõ âàðèàíòàõ ëå÷åíèÿ (âêëþ÷àÿ åñòåñòâåííî ðåêîíñòðóêòèâíóþ õèðóðãèþ).

Òàê âîò ýôôåêòèâíîñòü òàêîãî ëå÷åíèÿ ìîæåò äîñòèãàòü 40-50% íà ïðîöåäóðó, à êóììóëÿòèâíàÿ ÷àñòîòà (Feichtinger W. 1994)


  • 1 ïîïûòêà ÝÊÎ - 20-30% óñïåõà
  • 3 ïîïûòêè ÝÊÎ - 70-80% óñïåõà
  • 6 ïîïûòîê ÝÊÎ - 90-95% óñïåõà
ðèñê æå âíåìàòî÷íîé áåðåìåííîñòè íå áîëåå 4%. Îáðàùàþ Âàøå âíèìàíèå, ÷òî ýòî äàííûå åùå 1994 ãîäà.

ñì. äàëåå
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 30.09.2005, 21:03
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîîáùàâøèñü æå ñ õèðóðãîì, çäåñü õî÷ó ïîä÷åðêíóòü (èìåííî ñ õèðóðãîì) ò.ê. õèðóðã íå ðàññìàòðèâàåò àëüòåðíàòèâíûå ìåòîäû ËÅ×ÅÍÈß ÁÅÑÏËÎÄÈß, à ðóêîâîäñòâóåòñÿ óçêîíàïðàâëåííûìè ðåêîìåíäàöèÿìè ñîâðåìåííûõ ïîñîáèé ïî ÕÈÐÓÐÃÈÈ (õî÷ó ïîä÷åðêíóòü íå ïî ËÅ×ÅÍÈÞ ÁÅÑÏËÎÄÈß, ãäå ðàññìàòðèâàþòñÿ ðàçëè÷íûå âàðèàíòû ëå÷åíèÿ (è õèðóðãè÷åñêèå â òîì ÷èñëå), à òîëüêî âàðèàíòû õèðóðãè÷åñêîãî ëå÷åíèÿ) èíôîðìèðóåò ïàöèåíòà îá ýôôåêòèâíîñòè äàííîãî âèäà ëå÷åíèÿ.
 ïðèâåäåííûõ àðãóìåíòàõ â ïîëüçó ðåêîíñòðóêòèâíîé õèðóðãèè

Öèòàòà:
Âåðîÿòíîñòü çàáåðåìåíåòü ñ ñîõðàíåííîé òðóáîé áîëåå 80%, à áåç òðóáû - 0%.
Âû íå óñìàòðèâàåòå çäåñü äîëè ëóêàâñòâà?
×åëîâåêó íåïîñâÿùåííîìó äîñòàòî÷íî ñëîæíî ðàçîáðàòüñÿ ò.ê. öèôðû äåéñòâèòåëüíî âïå÷àòëÿþò, îäíàêî:


  • íå ðàññìàòðèâàåòñÿ âîîáùå âîçìîæíîñòü ïðèìåíåíèÿ àëüòåðíàòèâíûõ ìåòîäîâ ëå÷åíèÿ (è òîãäà ýòî íàâåðíîå íå 0%)
  • íå ðàññìàòðèâàåòñÿ ïðèìåíåíèå ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè, ãäå ñóììàðíàÿ ýôôåêòèâíîñòü ìîæåò äîñòèãàòü 90%.
  • ïðèâåäåííûå 80% ïðè îðãàíîñîõðàíÿþùåé îïåðàöèè – ýòî îòíþäü íå âåðîÿòíîñòü ïîëó÷èòü áåðåìåííîñòü.
  • íå ó÷èòûâàþòñÿ àíàìíåñòè÷åñêèå äàííûå (íå äóìàþ, ÷òî ïðè ïîâòîðíûõ ðåêîíñòðóêòèâíûõ âìåøàòåëüñòâàõ ðåçóëüòàòû ñòîëü æå îïòèìèñòè÷íû)
  • íå ðàññìàòðèâàåòñÿ âîçðàñò ïàöèåíòêè
  • íå ðàññìàòðèâàåòñÿ âîçìîæíîñòü ïîâòîðåíèÿ ýêòîïè÷åñêîé áåðåìåííîñòè
  • íå ðàññìàòðèâàåòñÿ ñóììàðíàÿ ñòîèìîñòü ïîëó÷åíèÿ æåëàåìîãî ðåçóëüòàòà (à ïðè ïîâòîðåíèè ýêòîïè÷åñêîé áåðåìåííîñòè (à 28% ýòî äîñòàòî÷íàÿ ñåðüåçíàÿ âåðîÿòíîñòü) è óäàëåíèè òðóáû ïàöèåíò çàïëàòèò óæå çà ÄÂÀ õèðóðãè÷åñêèõ âìåøàòåëüñòâà è ïëþñ ðàñõîäû íà ïðèìåíåíèå ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè.
Êñòàòè îá îñëîæíåíèÿõ:

PolMerkuriuszLek. 2005 Jan;18(103):74-7.Analysis of risk factors for ectopic pregnancy in own material in the years1993-2002 Brodowska A, Szydlowska I, Starczewski A, Strojny K, Puchalski A, Mieczkowska E,Wozniak W.
Klinika Rozrodczosci i Ginekologii Pomorskiej Akademii Medycznej w Szczecinie.,

The ectopic pregnancy is still a life-threatening condition. The risk factors for ectopic pregnancy are divided into four groups: 1) mechanic factors, 2) tubal dysfunction, 3) assisted reproductive techniques (ART) and 4) hormonal factors. MATERIAL AND METHODS: On basis of the analysis of medical documentation we determined the risk factors for ectopic pregnancy in 214 patients (aged 18-44, mean 32 +/- 9 years) hospitalized in Department of Reproductive Medicine and Gynecology of Pomeranian Medical University between 1993 and 2002. The control group composed 215 patients admitted to the hospital outpatient clinic in the years 1993-2002. RESULTS: The risk factors for ectopic pregnancyevaluated in each group of patients were: history of adnexitis, surgicalprocedures (appendectomy, tubal microsurgery, ovarian cystectomy, adnexectomy,myomectomy, cesarean section, previous conservative surgical treatment ofectopic pregnancy, salpingectomy), appendicitis complicated by peritonitis,endometriosis, conservative treatment of ectopic pregnancy, insertion of IUD,ovarian induction or IVF procedure, uterine defects and smoking. In the examinedgroup 104 patients had a history of surgery (48.5%) compare to 40 patients inthe control group (18.6%). Difference between groups issignificant p = 0,034.In 40 cases out of 104 (18.6%) surgical operations were done two and more times.Statistics proves that surgical procedures in the past occurred significantlymore frequently in the studied than in control group. The most frequentoperations were: conservative surgical treatment of ectopic pregnancy (p =0.000), tubal microsurgery (p = 0.0016), ovarian cystectomy (p = 0.013) andsalpingectomy (p = 0.047). Appendectomies or myomectomies in the past did notincrease the risk of ectopic pregnancy. Additionally, in the examined groupthere were more cases of MTX (Methotrexate) therapy applied in the past becauseof ectopic pregnancy (p = 0.000), more smoking (p = 0.0001) and more adnexitisin the past (p = 0.013). Treated endometriosis in the past, artificialreproductive techniques (ART), peritonitis, IUD application and uterine defectswere no important risk factors for ectopic pregnancy.

CONCLUSIONS: The main riskfactors for ectopic pregnancy are: history of surgical procedures, especiallyconservative surgical treatment of ectopic pregnancy and tubal microsurgery.

Appendectomy or myomectomy do not increase this risk. The other important riskfactors for ectopic pregnancy are: conservative treatment of ectopic pregnancyin the past and smoking. Adnexitis is another risk factor for ectopic pregnancy.

Ïîäîáíàÿ óçîñòü âçãëÿäîâ, íåæåëàíèå (à ìîæåò íåõîòåíèå) îöåíèâàòü ðåàëèè ñåãîäíÿøíåãî äíÿ âåñüìà õàðàêòåðíû äëÿ õèðóðãîâ-ãèíåêîëîãîâ, íå çàíèìàþùèõñÿ ñïåöèàëüíî ÏÐÎÁËÅÌÀÌÈ ÁÅÑÏËÎÄÈß.


ñì. äàëåå
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 30.09.2005, 21:09
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîäîáíûé ïîäõîä, êàê ìíå êàæåòñÿ, ÿâëÿåòñÿ èñòîðè÷åñêè ñëîæèâøèìñÿ (êîãäà íå ñóùåñòâîâàëî ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè) è ñîõðàíåíèå îñòàâøåéñÿ òðóáû ðàññìàòðèâàëîñü ñ ïîçèöèé ïóñòü ìèôè÷åñêîãî, íî øàíñà íàñòóïëåíèÿ áåðåìåííîñòè. Ïîÿâëåíèå æå ïîäîáíîé âîçìîæíîñòè íå èçìåíèëî ñëîæèâøèõñÿ ñòåðåîòèïîâ. Êðîìå òîãî, âñòóïëåíèå â ýðó ïëàòíîé ìåäèöèíû ïðèíåñëî ðÿä ôàêòîðîâ, î êîòîðûõ ðàíåå âðà÷ ïðîñòî íå çàäóìûâàëñÿ.

Äàâàéòå íå áóäåì ëóêàâèòü, íî ðåøåíèå îñòàâèòü åäèíñòâåííóþ ìàòî÷íóþ òðóáó çà÷àñòóþ îñíîâûâàåòñÿ íå íà íàäåæäå î åå ïîòåíöèàëüíîé âîçìîæíîñòè ïðèâåñòè ê æåëàåìîé áåðåìåííîñòè, à íà ñòðàõå î âîçìîæíîé îòâåòñòâåííîñòè (ðàíüøå ËÊÊ, à ñåãîäíÿ âñå ÷àùå ñóäû) è íåâîçìîæíîñòè àðãóìåíòèðîâàíî îáîñíîâàòü ñâîå ðåøåíèå. ×àùå âñåãî ïðè âîíèêíîâåíèè ïîäîáíîé ñèòóàöèè îïåðèðóþùèé õèðóðã âî âðåìÿ îïåðàòèâíîãî âìåøàòåëüñòâà ïûòàåòñÿ çàðó÷èòüñÿ ðàçðåøåíèåì çàâ. îòäåëåíèÿ. Íå òàê ëè?

Äåéñòâèòåëüíî ãîðàçäî ïðîùå îñòàâèòü “íèêàêóþ” ìàòî÷íóþ òðóáó, ÷åì ïîçæå ïûòàòüñÿ äîêàçàòü, ÷òî åå îñòàâëåíèå òîëüêî óâåëè÷èâàëî ðèñêè îñëîæíåíèé .

Äóìàþ, ÷òî åñëè áû ïàöèåíò áûë èíôîðìèðîâàí, ÷òî ÷àñòîòà ïîâòîðíûõ ýêòîïè÷åñêèõ áåðåìåííîñòåé íàõîäèòüñÿ â ïðåäåëàõ 30%, òî ïîñëå îäíîé, à äâóõ îïåðàöèé òàê òî÷íî îí íå äàë áû ñîãëàñèÿ íà ïðîâåäåíèå ïîäîáíîãî âìåøàòåëüñòâà.

Õèðóðã æå îáû÷íî îçâó÷èâàåò òîëüêî ïåðâóþ öèôðó î âîçìîæíîñòè íàñòóïëåíèÿ áåðåìåííîñòè.

Íå ëóêàâñòâî ëè ýòî???

Ïîäîáíûå óçêîíàïðàâëåííûå âçãëÿäû äîñòàòî÷íî ðàñïðîñòðàíåíû. Âåäü ñóùåñòâóþò è àíäðîëîãèè, êîòîðûå ãîäàìè ïîâûøàþò ïîêàçàòåëè ñïåðìîãðàììû ó ìóæ÷èíû, íå çàäàâàÿñü âîïðîñîì î òîì ÷òî ó ñóïðóãè , äîïóñòèì, îòñóòñòâóþò ìàòî÷íûå òðóáû, äà è êîëëåãè ãèíåêîëîãè â ïîäîáíîé æå ñèòóàöèè çàñòàâëÿþùèå æåíùèíó èçìåðÿòü áàçàëüíóþ òåìïåðàòóðó è ïð. ïð. ïð. Êñòàòè íàèáîëåå èçëþáëåííûì äèàãíîçîì ãèíåêîëîãîâ-ýíäîêðèíîëîãîì ÿâëÿåòñÿ ãèïåðïðîëàêòèíåìèÿ âíå çàâèñèìîñòè îò óðîâíÿ ïðîëàêòèíà è ñîîòâåòñòâåííî åå ëå÷åíèå âíå çàâèñèìîñòè îò ñîïóòñâóþùèõ äèàãíîçîâ.


ß íå ñëó÷àéíî ðàññìàòðèâàë âîïðîñ ËÅ×ÅÍÈß ÁÅÑÏËÎÄÈß (íå òàêòèêè õèðóðãà ïðè íàëè÷èè îäíîé ìàòî÷íîé òðóáû è ýêòîïè÷åñêîé áåðåìåííîñòè) è ñ ïîçèöèé “cost-ýôôåêòèâíîñòè ".

Prim. Care Update Ob Gyns. 1998 Jul 1;5(4):168. Tubal surgery vs in vitro fertilization for the treatment of infertility due todistal tubal occlusion. Nichols KP, Steinkampf MP.
The University of Alabama at Birmingham, USA
Background: The optimal treatment of infertility due to tubal occlusion has notbeen established. Many practitioners feel that the success of tubal repairexceeds that of in vitro fertilization (IVF); however, previous studies ofpregnancy after tubal surgery have been limited by bias in patient selection,follow-up, or surgical expertise. The purpose of the present study was todetermine the outcome after repair of distal tubal occlusion performed byexperienced surgeons in an unselected patient population with consistentfollow-up.
Design: Chart review with telephone contact of patients lost tofollow-up.
Methods: The records of all tubal surgery performed between 1989 and1996 at the University of Alabama Hospital and The Kirklin Clinic outpatientsurgery facility were reviewed. All women with infertility due to distal tubalocclusion, with or without pelvic adhesions, who had no other significantinfertility factors were included for study. Details of the infertility history,operative procedure, and postoperative course were recorded. Patients lost tofollow-up within 1 year after surgery were contacted by telephone forinformation regarding subsequent testing and treatment and pregnancyoutcome.Results: Eighty-three women aged 19-39 years met the entry criteria forthis study. Follow-up of at least 1 year was obtained in all but 11 patients.Tubal surgery was accomplished by laparotomy in 19 women; 64 women underwenttubal repair by laparoscopy. Within 1 year of surgery, 9 hysterosalpingograms,51 clomiphene cycles, and 20 gonadotropin cycles wereperformed on the studygroup. Pregnancy was achieved within 1 year in 13 women; of these, there were 6live births (9.6% birth rate per surgery), 2 spontaneous abortions, and 3ectopic pregnancies. There were no live births among women who underwent tubalrepair by laparotomy. None of the postoperative gonadotropin cycles resulted inpregnancy. Seven women underwent IVF within 1 year after surgery because ofextensive tubal damage noted at surgery. Based on current charges for theinfertility treatments performed, the cost of a live birth with tubal surgeryexceeded $120,000, versus less than $50,000 per live birth with IVF usingresults obtained nationally or at UAB.
Conclusions: The cost-effectiveness ofreconstructive surgery in unselected patients with distal tubal occlusion isless than that of IVF. Empiric use of gonadotropins for ovarian stimulation doesnot improve pregnancy rates after tubal surgery. In our series, laparoscopictubal repair seemed to give results superior to that of laparotomy.

Ïîäîáíàÿ èíôîðìàöèÿ çàñòàâèò ïîäóìàòü î âûáîðå ìåòîäà ëå÷åíèÿ.

ñì. äàëåå
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 30.09.2005, 21:19
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êñòàòè è â ñîîáùåíèè ïàöèåíòêè ãîâîðèòñÿ î ðåêîìåíäàöèè ïðèìåíåíèÿ ìåòîäîâ ÂÐÒ.

Öèòàòà:
Òðóáó ñîõðàíèëè (îíà ó ìåíÿ åäèíñòâåííàÿ), íî áåðåìåíåòü åñòåñòâåííûì ñïîñîáîì íå ðåêîìåíäîâàëè.
Êàê Âû ïîëàãàåòå, ñ ÷åãî áû ýòî õèðóðã, ïðîâîäèâøèé âìåøàòåëüñòâî, íå ðåêîìåíäóåò æåíùèíå ïûòàòüñÿ çàáåðåìåíåòü åñòåñòâåííûì ïóòåì????

Ïî-âèäèìîìó, îí òàêæå îïàñàåòñÿ íàñòóïëåíèÿ ïîñëåäóþùåé ýêòîïè÷åñêîé áåðåìåííîñòè â èçìåíåííîé è îïåðèðîâàííîé ìàòî÷íîé òðóáå, õîòÿ è íå ïðåäïîëàãàåò (êàê ñëåäóåò èç ñîîáùåíèÿ), ÷òî
ïðîâåäåíèå ýêî ïðè ñîõðàíåííûõ ìàòî÷íûõ òðóáàõ íå èñêëþ÷àåò íàñòóïëåíèÿ ýêòîïè÷åñêîé áåðåìåííîñòè.
Ïî÷åìó æå îí åå îñòàâëÿåò??

Òîëüêî ïîòîìó, ÷òîáû â ñëó÷àå âîçíèêíîâåíèÿ ïðåòåíçèé, íå çàíèìàòüñÿ îáúÿñíåíèÿìè î öåëåñîîáðàçíîñòè ïîäîáíîãî ðåøåíèÿ. Ò.å. èì (äà è íå òîëüêî ýòèì îòäåëüíî âçÿòûì õèðóðãîì) â äàííîé ñèòóàöèè ðóêîâîäèò íå êëèíè÷åñêîå ìûøëåíèå, à ñóùåñòâóþùèå ñòåðåîòèïû è áîÿçíü ïîòåíöèàëüíîé âîçìîæíîñòè äàâàòü àðãóìåíòèðîâàííûå îáúÿñíåíèÿ ñâîåãî ðåøåíèÿ.

Åñòåñòâåííî èç äâóõ ðåøåíèé îí ïðèíèìàåò íàèáîëåå ïðîñòîå.

Íå ñåêðåò, ÷òî è ñåãîäíÿ ïðè íàëè÷èè ãîðàçäî áîëåå îáúåêòèâíûõ ìåòîäîâ îáñëåäîâàíèÿ (ãîðìîíàëüíîå èññëåäîâàíèå, óëüòðàçâóêîâîå èññëåäîâàíèå) èñïîëüçóþòñÿ àðõàè÷íûå ìåòîäû (èçìåðåíèå áàçàëüíîé òåìïåðàòóðû).  ïîäàâëÿþùåì áîëüøèíñòâå ïîäîáíûé ïîäõîä ñâÿçàí íå ñ îòñóòñòâèåì ìàòåðèàëüíîé áàçû, à ñî ñëîæèâøèìèñÿ ñòåðåîòèïàìè.



 çàêëþ÷åíèè ìîãó ëèøü ñêàçàòü, ÷òî


  • Íåëüçÿ ðàññìàòðèâàòü ËÅ×ÅÍÈÅ ÁÅÑÏËÎÄÈß ñ ïîçèöèé óçêîïðîôåññèîíàëüíûõ
  • Ïàöèåíò ïðè ïëàíèðîâàíèè ëå÷åíèÿ ÂÏÐÀÂÅ È ÄÎËÆÅÍ ïîëó÷èòü ÏÎËÍÓÞ èíôîðìàöèþ îòíîñèòåëüíî ïåðñïåêòèâ ëå÷åíèÿ è âîçìîæíûõ îñëîæíåíèé.
C óâ. ìîäåðàòîð ôîðóìà
Á. Êàìåíåöêèé

PS: Êñòàòè íå âðåäíî ïî÷èòàòü îáçîð Áåëîáîðîäîâà Ñ.Ì. î ôèçèîëîãèè ìàòî÷íûõ òðóá, êîòîðûé ëåæèò çäåñü: http://forums.rusmedserv.com/showthr...F0%EE%E4%EE%E2
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 01.10.2005, 16:37
Àâàòàð äëÿ dr_medvedev
dr_medvedev dr_medvedev âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 24.07.2004
Ãîðîä: Óêðàèíà, Äíåïðîïåòðîâñê
Ñîîáùåíèé: 1,367
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
dr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Áîðèñ Àëåêñàíäðîâè÷!
Ñïàñèáî çà ïîäðîáíûå îòâåòû. Äåëî â òîì, ÷òî ÿ ïîëíîñòüþ ñ Âàìè ñîãëàñåí:

1. Ðåêîíñòðóêòèâíàÿ õèðóðãèÿ òðóá - èñòîðèÿ ìåäèöèíû è, åñòåñòâåííî, ïîâòîðíûå îïåðàöèè ïî ïîâîäó ïåðèòîíåàëüíîãî áåñïëîäèÿ ìîæíî òðàêòîâàòü êàê âðà÷åáíóþ îøèáêó. Îãîâîðþñü, ÷òî áûâàþò ñëó÷àè ñìåøàííîãî áåñïëîäèÿ, êîãäà íàðÿäó ñî ñïàéêàìè ìû èìååì ÑÏÊß è êàóòåðèçàöèÿ ÿè÷íèêîâ äåéñòâèòåëüíî ÿâëÿåòñÿ ïîëåçíûì ìåðîïðèÿòèåì.
2. ß òàêæå ïðåáûâàþ â øîêå îò çàñèëüÿ ÁÀÄîâ è êîøìàðíûõ àëãîðèòìîâ ëå÷åíèÿ áåñïëîäèÿ, êîòîðûå ïðèìåíÿþò ãèíåêîëîãè (çà àíäðîëîãîâ-óðîëîãîâ íå ñòàëêèâàþñü).
3.  ëå÷åíèè áåñïëîäèÿ, êàê, âïðî÷åì, è ìíîãèõ äðóãèõ çàáîëåâàíèé, íåò ÷èñòî õèðóðãè÷åñêîãî èëè ìåäèêàìåíòîçíîãî ìåòîäîâ ëå÷åíèÿ. Åñòü ðåêîìåíäàöèè, îñíîâàííûå íà äîêàçàòåëüíûõ èññëåäîâàíèÿõ êîòîðûå ó÷èòûâàþò â òîì ÷èñëå è "cost-effectiveness". Òî æå ñàìîå êàñàåòñÿ ìåòîäîâ äèàãíîñòèêè.
4. "Ïàöèåíò ïðè ïëàíèðîâàíèè ëå÷åíèÿ ÂÏÐÀÂÅ È ÄÎËÆÅÍ ïîëó÷èòü ÏÎËÍÓÞ èíôîðìàöèþ îòíîñèòåëüíî ïåðñïåêòèâ ëå÷åíèÿ è âîçìîæíûõ îñëîæíåíèé" - Âàøà öèòàòà.

Ïî÷åìó âðà÷ ñîâåòóåò ÝÊÎ è îñòàâëÿåò ïðè ýòîì òðóáó? Çäåñü èìååòñÿ ÿâíîå ðàñõîæäåíèå. Êîíå÷íî áûëî íåöåëåñîîáðàçíî îñòàâëÿòü òðóáó, ðåêîìåíäóÿ ÝÊÎ. Íî, ñ òðóäîé ñòîðîíû, åñëè òðóáó îñòàâèëè ìîæíî ïîïûòàòüñÿ îáîéòèñü áåç ÝÊÎ (õîòÿ áû êàêîå-òî âðåìÿ) ó÷èòûâàÿ, òî, ÷òî ÝÊÎ â íàøèõ ñòðàíàõ îáîéäåòñÿ ÿâíî äîðîæå âûæèäàòåëüíîé òàêòèêè (åñëè îíà, êîíå÷íî, äàñò ðåçóëüòàò).

ß äóìàþ, ÷òî ïðè÷èíû, ïî êîòîðûì îñòàâèëè òðóáó, Âû ïîäìåòèëè ïðàâèëüíî.

È âñå æå ñîãëàñèòåñü, ÷òî íàì ïîêà íå óäàëîñü íàéòè èññëåäîâàíèé, êîòîðûå ïîñòàâèëè áû òî÷êó â âîïðîñå ñòîèò ëè ñîõðàíÿòü åäèíñòâåííóþ òðóáó ïðè ïåðâîé âíåìàòî÷íîé áåðåìåííîñòè è íîðìàëüíûõ ðîäàõ â àíàìíåçå èëè åå íóæíî ñðàçó æå óáðàòü è íàïðàâèòü æåíùèíó íà ÝÊÎ?

ß åùå îñîáî íå ñìîòðåë èíôîðìàöèþ ïî ýòîìó ïîâîäó. Ìîæåò áûòü ìíå óäàñòñÿ ÷òî-íèáóäü íàéòè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 01.10.2005, 20:08
Àâàòàð äëÿ Áîðèñ Êàìåíåöêèé
Áîðèñ Êàìåíåöêèé Áîðèñ Êàìåíåöêèé âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.07.2001
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 5,200
Ïîáëàãîäàðèëè 1,529 ðàç(à) çà 1,416 ñîîáùåíèé
Áîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÁîðèñ Êàìåíåöêèé ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò dr_medvedev
È âñå æå ñîãëàñèòåñü, ÷òî íàì ïîêà íå óäàëîñü íàéòè èññëåäîâàíèé, êîòîðûå ïîñòàâèëè áû òî÷êó â âîïðîñå ñòîèò ëè ñîõðàíÿòü åäèíñòâåííóþ òðóáó ïðè ïåðâîé âíåìàòî÷íîé áåðåìåííîñòè è íîðìàëüíûõ ðîäàõ â àíàìíåçå èëè åå íóæíî ñðàçó æå óáðàòü è íàïðàâèòü æåíùèíó íà ÝÊÎ?
Åñòåñòâåííî íåò.
Åñëè îïåðàöèÿ ïëàíîâàÿ, ýêòîïè÷åñêàÿ áåðåìåííîñòü ïåðâàÿ, îòñóòñòâóþò ïðåäøåñòâóþùèå õèðóðãè÷åñêèå âìåøàòåëüñòâà, âîçðàñò ïàöèåíòêè íå áîëåå 35 ïëþñ ðåàëüíàÿ îöåíêà ñîñòîÿíèÿ ìàòî÷íîé òðóáû, ÿ áû ðåêîìåíäîâàë òðóáó ñîõðàíèòü.

Ñ óâ. Á.Êàìåíåöêèé
Îòâåòèòü ñ öèòèðîâàíèåì
  #26  
Ñòàðûé 01.10.2005, 20:11
Àâàòàð äëÿ Litta
Litta Litta âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 20.08.2005
Ãîðîä: Litva
Ñîîáùåíèé: 124
Litta ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Äëÿ ìåíÿ îñòà¸òñÿ íåðåø¸ííûì âîïðîñ: "Íåóæåëè, îïåðàöèÿ ïî ñîõðàíåíèþ ìàòî÷íîé òðóáû ïðîùå, ÷åì óäàëåíèå å¸ æå?" Ñîìíåâàþñü, ÷òî âûáðàí áîëåå ïðîñòîé âàðèàíò ðåøåíèÿ ïðîáëåìû.
Îòâåòèòü ñ öèòèðîâàíèåì
  #27  
Ñòàðûé 01.10.2005, 20:25
Àâàòàð äëÿ Litta
Litta Litta âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 20.08.2005
Ãîðîä: Litva
Ñîîáùåíèé: 124
Litta ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Ê ìîåìó áîëüøîìó ñîæàëåíèþ, îïåðàöèÿ áûëà ýêñòðåííîé, ÷òî â êîðíå ïîäîðâàëî ìî¸ äîâåðèå ê íàøåé ìåäèöèíå. Äåëî â òîì, ÷òî ÿ ñàìà ëåãëà â ñòàöèîíàð ñ ïîäîçðåíèåì íà âíåìàòî÷íóþ, íî, ïðîäåðæàâ 3 äíÿ, íà îáùåì ñîáðàíèè áûëî ðåøåíî ìåíÿ îòïóñòèòü. Âå÷åðîì òîãî æå äíÿ ÿ áûëà äîñòàâëåíà íà ñêîðîé â òó æå áîëüíèöó, íî óæå ñ âíóòðåííèì êðîâîòå÷åíèåì.
Çäåñü âñÿ ìîÿ èñòîðèÿ îò íà÷àëà äî êîíöà:
http://forums.rusmedserv.com/showthr...3&page=1&pp=15

ß î÷åíü áëàãîäàðíà Ìèõàèëó Âëàäèìèðîâè÷ó çà ïîääåðæêó è ñîâåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #28  
Ñòàðûé 01.10.2005, 20:31
Àâàòàð äëÿ dr_medvedev
dr_medvedev dr_medvedev âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 24.07.2004
Ãîðîä: Óêðàèíà, Äíåïðîïåòðîâñê
Ñîîáùåíèé: 1,367
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
dr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàê âèäèòå â ðåçóëüòàòå äèñêóññèè, óõîäÿùåé íåìíîãî çà ïðåäåëû Âàøåé êîíêðåòíîé ïðîáëåìû, ìû ñ Áîðèñîì Àëåêñàíäðîâè÷åì ïðèøëè ê åäèíîìó íà ñåãîäíÿøíèé äåíü ìíåíèþ, ÷òî ñîõðàíåíèå Âàøåé òðóáû áûëî îïðàâäàííûì, ó÷èòûâàÿ ðîäû, ÷òî ýòî áûëà ïåðâàÿ âíåìàòî÷íàÿ áåðåìåííîñòü (åå ìîæíî ïðèðàâíÿòü ê ïëàíîâîé, ò.ê. ïðåðûâàíèå ïðîèñõîäèëî ïî âñåé âèäèìîñòè ïî òèïó òðóáíîãî àáîðòà, õîòÿ îïÿòüæå êàê ìû óæå îáñóæäàëè ìîæíî áûëî óñïåòü ïðîëå÷èòü åå êîíñåðâàòèâíî ìåòîòðåêñàòîì) è ÷òî ó Âàñ åäèíñòâåííàÿ òðóáà.
Ñîõðàíèòü òðóáó íåìíîãî ñëîæíåå, ÷åì óáðàòü, ò.ê. åñòü ðèñê ïåðñèñòåíöèè òðîôîáëàñòà, íåìíîãî âûøå ðèñê êðîâîòå÷åíèÿ è, êîíå÷íî, ðèñê ïîâòîðíîé âíåìàòî÷íîé.
Îòâåòèòü ñ öèòèðîâàíèåì
  #29  
Ñòàðûé 01.10.2005, 20:38
Àâàòàð äëÿ dr_medvedev
dr_medvedev dr_medvedev âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 24.07.2004
Ãîðîä: Óêðàèíà, Äíåïðîïåòðîâñê
Ñîîáùåíèé: 1,367
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
dr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìådr_medvedev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò boris
Åñòåñòâåííî íåò.
Åñëè îïåðàöèÿ ïëàíîâàÿ, ýêòîïè÷åñêàÿ áåðåìåííîñòü ïåðâàÿ, îòñóòñòâóþò ïðåäøåñòâóþùèå õèðóðãè÷åñêèå âìåøàòåëüñòâà, âîçðàñò ïàöèåíòêè íå áîëåå 35 ïëþñ ðåàëüíàÿ îöåíêà ñîñòîÿíèÿ ìàòî÷íîé òðóáû, ÿ áû ðåêîìåíäîâàë òðóáó ñîõðàíèòü.

Ñ óâ. Á.Êàìåíåöêèé
ß òîæå òàê ðåêîìåíäóþ ñäåëàòü íàøåé ïàöèåíòêå. Íî õîòåëîñü áû íàéòè êàêèå-íèáóäü èññëåäîâàíèÿ. Âîçìîæíî, â áóäóùåì äåéñòâèòåëüíî áîëåå öåëåñîîáðàçíîé ñî âñåõ òî÷åê çðåíèÿ áûëà áû òóáýêòîìèÿ ñ ïîñëåäóþùèì ÝÊÎ. Ñåáåñòîèìîñòü ÝÊÎ, íàñêîëüêî ÿ çíàþ, ïîñòîÿííî ñíèæàåòñÿ, à ýôôåêòèâíîñòü ðàñòåò. Ïîÿâÿòñÿ êèòàéñêèå àãîíèñòû-ÃÐà ïî 10 äîë/ìåñ è áóäåò ó íàñ îäíî ëå÷åíèå áåñïëîäèÿ - ÝÊÎ. Êàê Âû äóìàåòå íàñ÷åò òàêèõ ïåðñïåêòèâ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #30  
Ñòàðûé 01.10.2005, 20:40
Àâàòàð äëÿ Litta
Litta Litta âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 20.08.2005
Ãîðîä: Litva
Ñîîáùåíèé: 124
Litta ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Òî åñòü, êàê òîëüêî ìîðàëüíî ÿ áóäó ãîòîâà ê ïîâòîðíîé îïåðàöèè, ÿ ñìîãó ïëàíèðîâàòü áåðåìåííîñòü åñòåñòâåííûì ïóò¸ì?

Áëàãîäàðþ âàñ, Ìèõàèë Âëàäèìèðîâè÷, è âàñ, Áîðèñ Àëåêñàíäðîâè÷, çà âíèìàíèå ê ìîåé ïðîáëåìå.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 00:38.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.